![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 16853-16859, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biomolecular Sciences, University of
Manchester Institute of Science and Technology, Manchester M60 1QD,
United Kingdom and the
Received for publication, January 18, 2002
The irreversible oxidation of cysteine residues
can be prevented by protein S-thiolation, a process by
which protein -SH groups form mixed disulfides with low molecular
weight thiols such as glutathione. We report here that this protein
modification is not a simple response to the cellular redox state,
since different oxidants lead to different patterns of protein
S-thiolation. SDS-polyacrylamide gel electrophoresis shows
that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is the major
target for modification following treatment with hydroperoxides
(hydrogen peroxide or tert-butylhydroperoxide), whereas
this enzyme is unaffected following cellular exposure to the thiol
oxidant diamide. Further evidence that protein S-thiolation is tightly regulated in response to oxidative stress is provided by the
finding that the Tdh3 GAPDH isoenzyme, and not the Tdh2 isoenzyme, is
S-thiolated following exposure to
H2O2 in vivo, whereas both GAPDH
isoenzymes are S-thiolated when
H2O2 is added to cell-free extracts. This
indicates that cellular factors are likely to be responsible for the
difference in GAPDH S-thiolation observed in
vivo rather than intrinsic structural differences between the
GAPDH isoenzymes. To begin to search for factors that can regulate the
S-thiolation process, we investigated the role of the
glutaredoxin family of oxidoreductases. We provide the first evidence
that protein dethiolation in vivo is regulated by a
monothiol-glutaredoxin rather than the classical glutaredoxins, which contain two active site cysteine residues. In particular, glutaredoxin 5 is required for efficient dethiolation of the Tdh3 GAPDH isoenzyme.
Sulfydryl (-SH) groups play a remarkably broad range of roles in
the cell, with their redox state affecting the activity and structure
of many enzymes, receptors, and transcription factors. As a result, all
organisms contain complex regulatory machinery to maintain the redox
states of -SH groups in both proteins and low molecular weight
sulfydryls (reviewed in Refs. 1-3). However, cysteine residues are
among the most easily oxidized residues in proteins, and oxidation can
result in intermolecular protein cross-linking and enzyme inactivation,
eventually leading to cell death (4). Such irreversible oxidation
events can be prevented by protein S-thiolation, in which
protein -SH groups form mixed disulfides with low molecular weight
thiols such as GSH (5, 6).
A variety of proteins that become S-thiolated in response to
cellular stress have been detected in mammalian cells. These include
key metabolic enzymes such as carbonic anhydrase, glycogen phosphorylase, creatine kinase, glyceraldehyde 3-phosphate
dehydrogenase (GAPDH),1
glutathione transferase, and superoxide dismutase as well as structural
and transport proteins such as hemoglobin, actin, and crystallin
(reviewed in Ref. 6). Studies have also suggested that this
modification may be involved in the regulation of the function and
activity of proteins, including the human immunodeficiency virus type 1 protease (7), ubiquitin-conjugating enzymes in bovine retina cells (8),
and DNA binding by the transcription factor c-Jun (9). There does not
appear to be any one unifying feature of the proteins that become
S-thiolated apart from their relative abundance in mammalian
cells. Not all -SH-containing proteins are thiolated in response to an
oxidative stress, and the specificity of this protein modification
indicates that it must be a tightly regulated process. However, the
exact role of thiolation in protection against reactive oxygen
species-mediated damage is unknown, as are the consequences of this
process on cell growth and metabolism.
Recent studies in yeast have shown that protein S-thiolation
is important for survival during exposure to oxidative stress conditions. The basal levels of S-thiolation are maintained
at low levels, but they are increased following treatment with hydrogen peroxide (10). GAPDH was identified as the major target of protein S-thiolation following exposure to
H2O2 (11). This protein modification to GAPDH
is tightly regulated, since, despite a high degree of sequence homology
(98% similarity, 96% identity), the Tdh3, but not the Tdh2 GAPDH
isoenzyme was S-thiolated. Furthermore, activity of both the
Tdh2 and Tdh3 GAPDH isoenzymes was reduced following exposure to
H2O2, but only Tdh3 activity was restored
within a 1-h recovery period, indicating that S-thiolation
of the Tdh3 polypeptide was readily reversible. This protein
modification was also shown to be physiologically important, since
mutants lacking TDH3 showed increased sensitivity to a
challenge with H2O2, indicating that the
S-thiolated Tdh3 polypeptide is required for survival during
conditions of oxidative stress. In contrast, the nonthiolated Tdh2
polypeptide was required for survival during exposure to continuous low
levels of oxidants, conditions in which the Tdh3 polypeptide was
S-thiolated and hence inactive. These findings supported a
model in which both enzymes are required for survival during conditions
of oxidative stress, playing complementary roles depending on their
ability to undergo S-thiolation (11).
Taken together, these previous studies indicate that protein
S-thiolation is a novel form of post-translational
modification regulating protein activity in response to growth or other
cellular signals. Protein S-thiolation must therefore be
reversible, and in vitro studies have shown that
dethiolation can occur via direct reduction by GSH as well as
enzymatically via both glutaredoxins and thioredoxins (5, 12).
Glutaredoxin appears to be the most active dethiolase, and in addition,
a recent study has shown a correlation between protein-SSG reduction
and glutaredoxin activity in mammalian cells (13). However, little is
known about the factors regulating this protein modification in
vivo. In this study, we provide the first in vivo
evidence that protein dethiolation can be catalyzed by a
monothiol-glutaredoxin rather than the classical glutaredoxins,
which contain two active site cysteine residues.
Yeast Strains and Growth Conditions--
The Saccharomyces
cerevisiae strains used in this study are described in Table
I. The double
grx3::kanMX4
grx5::kanMX4 and grx4::kanMX4
grx5::kanMX4 mutant strains were constructed
using standard yeast genetic methods. Strains were grown in rich YEPD medium (2% (w/v) glucose, 2% (w/v) bactopeptone, 1% (w/v) yeast extract) or minimal SD medium (0.17% (w/v) yeast nitrogen base without amino acids, 5% (w/v) ammonium sulfate, 2% (w/v) glucose) supplemented with appropriate amino acids and bases: 2 mM
leucine, 4 mM isoleucine, 1 mM valine, 0.3 mM histidine, 0.4 mM tryptophan, 1 mM lysine, 0.15 mM adenine, 0.2 mM
uracil. Media were solidified by the addition of 2% (w/v) agar.
Sensitivity to oxidants was determined by growing cells to exponential
phase in SD medium at 30 °C and treating with the required oxidant.
Aliquots of cells were diluted into fresh YEPD medium and plated in
triplicate on YEPD plates to obtain viable counts after 3 days of
growth.
Determination of Glutathione Levels--
Glutathione levels were
determined as described previously (10). Briefly, cells were grown in
minimal SD medium to an A600 of 1 (1-2 × 107 cells/ml) and harvested by centrifugation. Cells were
washed twice with phosphate-buffered saline (pH 7.4) to remove any
traces of growth medium and resuspended in ice-cold 8 mM
HCl, 1.3% (w/v) 5-sulfosalicyclic acid. Cells were broken with glass
beads using a Minibead beater (Biospec Scientific, Bartlesville, OK)
for 30 s at 4 °C before incubating on ice for 15 min to
precipitate proteins. Cell debris and proteins were pelleted in a
microcentrifuge for 15 min (13,000 rpm, 4 °C), and the supernatant
was used for the determination of free glutathione.
Analysis of Protein S-Thiolation--
The analysis of protein
S-thiolation in yeast has been described previously (11).
Briefly, yeast cells were grown to exponential phase in minimal SD
medium and treated with 50 µg/ml cycloheximide for 15 min to inhibit
cytoplasmic protein synthesis. The intracellular pool of low molecular
weight sulfydryls was radiolabeled by incubating cells with ~0.5
nM L-[35S]cysteine/methionine for
1 h. Cells were then washed and resuspended in fresh SD
medium with oxidants to induce S-thiolation.
Cell-free extracts were prepared in 20 mM sodium phosphate
buffer, pH 7.4, containing 100 mM phenylmethylsulfonyl
fluoride, by breaking cells with glass beads using a Minibead Beater
for 30 s at 4 °C. Parallel extracts were prepared in buffer
containing either 50 mM N-ethylmaleimide (NEM)
to prevent thiolation during the sample preparation, or 25 mM dithiothreitol (DTT) to reduce any
S-thiolated proteins. To follow dethiolation, cells were
resuspended in fresh SD medium containing 50 µg/ml
cycloheximide to inhibit protein synthesis. To quantify protein
S-thiolation, aliquots of cell extracts were precipitated on
Whatman GF/C glass microfiber filters using 10% (w/v) trichloroacetic
acid. Radioactive incorporation was measured by scintillation counting
and S-thiolation expressed as the difference between the
NEM- and DTT-treated extracts (cpm/µg of protein). Proteins were
separated by SDS-polyacrylamide gel electrophoresis and visualized
using a Typhoon 8600 Imaging system (Amersham Biosciences). Quantification on gels was performed using ImageQuant Solutions software (Amersham Biosciences), and S-thiolation was again
expressed as the difference between the NEM- and DTT-treated extracts.
GAPDH Enzyme Assays--
GAPDH activity was measured according
to McAlister and Holland (14) and expressed as µmol of NADH formed
per min per µg of protein.
Western Blot Analysis--
Protein extracts were electrophoresed
under reducing conditions on 10% SDS-PAGE minigels and electroblotted
onto polyvinylidene difluoride membrane (Amersham Biosciences). The
blot was incubated in 2 µg/ml anti-GAPDH monoclonal antibody (MAB374;
Chemicon International Inc., Temecula, CA). Bound antibody was
visualized by chemiluminescence (ECL; Amersham Biosciences) following
incubation of the blot in rabbit anti-mouse immunoglobulin-horseradish
peroxidase conjugate (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Effect of Different Oxidants on Protein S-Thiolation--
To
characterize the effects of oxidative stress induced by different
oxidants on protein S-thiolation, the intracellular pool of
low molecular weight sulfydryls was radiolabeled as described under
"Experimental Procedures." Cells were challenged with 2 mM H2O2,
tert-butylhydroperoxide, or diamide, and cell extracts were
prepared in the presence of NEM to prevent S-thiolation
during the extraction procedure or with DTT to reduce any
S-thiolated proteins. The levels of protein
S-thiolation were quantified as the difference in counts
incorporated between the NEM- and DTT-prepared extracts (Fig.
1A). The basal level of
S-thiolation in unstressed cells was very low but increased
following treatment with all three oxidants.
H2O2 and tert-butylhydroperoxide
caused a similar increase in protein S-thiolation, whereas
that from diamide was much lower.
To determine the number and range of proteins that are
S-thiolated following treatment with the different oxidants,
total cell extracts were examined by SDS-PAGE (Fig. 1B). As
expected from the radioactive counts, few S-thiolated
proteins were detected in unstressed cells, whereas, several proteins
were detected following exposure to oxidants. Treatment with 2 mM H2O2 or
tert-butylhydroperoxide induced a similar pattern of protein
S-thiolation. In both cases, a prominent protein of ~38
kDa was detected, which we have previously identified as GAPDH (11). In
addition, several unknown proteins were S-thiolated in
response to both oxidants (e.g. of 45, 70, and 100 kDa).
These unknown proteins were also detected following treatment with
diamide, but surprisingly, diamide did not induce protein
S-thiolation of GAPDH. Radioactivity incorporation was confirmed to occur as a result of S-thiolation, since it was
reversed by treatment with DTT. These results confirm that protein
S-thiolation is tightly regulated in the cell and indicate
that different oxidant treatments result in different patterns of modification.
Protein S-Thiolation Does Not Correlate with Cellular Redox State
or Viability--
To determine whether this difference in
S-thiolation arose as a result of the oxidants having
different effects on the cellular oxidation state, we determined
whether the increases in protein S-thiolation levels
correlated with changes in the cellular redox state. Glutathione is the
most abundant low molecular weight sulfydryl, and differences in the
ratio of reduced to oxidized glutathione (GSH/GSSG) can be used as a
sensitive indicator of the overall redox balance (15). Exponential
phase yeast cells grown under normal aerobic conditions have a high
glutathione redox ratio, indicating that most glutathione is maintained
in a reduced (GSH) form (16, 17). Treatment with both 2 mM
H2O2 and tert-butylhydroperoxide reduced the GSH/GSSG ratio, but to different extents (Fig.
2B). H2O2 treatment at this concentration did not
increase the levels of GSSG, but it decreased GSH by ~40% (Fig.
2A), reducing the GSH/GSSG ratio from 188 in the control
culture to 137. In contrast, tert-butylhydroperoxide
elevated GSSG levels by approximately 6-fold, reducing the GSH/GSSG
ratio to 32. Diamide, which is a membrane-permeable thiol-specific
oxidant (18), readily oxidized glutathione, resulting in a greater than
40-fold increase compared with the control culture (Fig.
2A). This caused a much reduced GSH/GSSG ratio (4.8),
indicating that ~15% of the total free glutathione was present in an
oxidized form following treatment with diamide (Fig. 2B).
Thus, protein S-thiolation did not correlate with changes in
the cellular redox state, since the diamide treatment caused a large
reduction in the cellular redox balance but only a small increase in
the levels of S-thiolation compared with the other oxidants.
In addition, there was no correlation between the levels of protein
S-thiolation and cell viability. Treatments with 2 mM tert-butylhydroperoxide or diamide did not
affect viability (Fig. 2C), whereas 2 mM
H2O2 resulted in greater than 90% loss of cell
viability within 1 h. Thus, protein S-thiolation is a regulated process that occurs in response to particular stress conditions. In order to identify the processes responsible for this
regulation, we next examined protein S-thiolation of GAPDH as a model protein.
Both Tdh2 and Tdh3 Can Be S-Thiolated in Vitro--
Three unlinked
genes (TDH1, TDH2, and TDH3) encode
isoenzymes of GAPDH in yeast (19). We have previously shown that the Tdh3 isoenzyme, but not the Tdh2 isoenzyme, is S-thiolated
in response to oxidative stress (11). This difference in
S-thiolation between the Tdh2 and Tdh3 polypeptides might
arise due to differences in their structures that affect the
accessibility of sulfydryl groups to S-thiolation, or
alternatively, the difference might be due to trans-acting factors that
regulate the process in the cell. To discriminate between these two
possible mechanisms, we examined the ability of Tdh2 and Tdh3 to be
S-thiolated in vitro. Specifically, the pool of
low molecular weight sulfydryls was radiolabeled in the wild-type
strain and in the tdh1 tdh2 and tdh1 tdh3
mutants. No S-thiolation was detected in the absence of
oxidative stress (Fig. 3A,
-H2O2 lanes). Treatment of cells with H2O2 resulted in
S-thiolation of GAPDH in strains containing Tdh3 (wild type
and tdh1 tdh2) but not in strains that lacked Tdh3
(tdh1 tdh3), confirming that Tdh3 is the
S-thiolated isoenzyme of GAPDH (Fig. 3A,
+H2O2 lanes).
Cell-free extracts were prepared from the nonstressed strains and
treated with 1 mM H2O2 for 30 min
at 30 °C in vitro (Fig. 3B). No
S-thiolation was detected in the unstressed extracts, but
GAPDH was S-thiolated in response to treatment with
H2O2 in extracts from all three strains.
Radiolabeling was confirmed to occur as a result of
S-thiolation, since it was reversed by treatment with DTT.
Thus, unlike the situation found in cells (Fig. 3A), Tdh2 as
well as Tdh3 can be S-thiolated in vitro (Fig.
3B). This indicates that cellular factors are likely to be
responsible for the differences in GAPDH S-thiolation
observed in vivo rather than differences in structure
between the GAPDH isoenzymes. To begin to search for possible
trans-acting factors that might regulate the S-thiolation
process, we next examined protein S-thiolation in mutants
lacking glutaredoxins.
Regulation of GAPDH Activity in Glutaredoxin Mutants--
We have
previously identified two genes, designated GRX1 and
GRX2, in yeast that encode glutaredoxins (20). Mutants
lacking GRX1 and GRX2 were unaffected in mixed
disulfide formation (20), and similarly, S-thiolation of
GAPDH is unaffected in grx1 and grx2 mutants
(data not shown). Recently, a new family of glutaredoxin-related proteins has been identified in yeast (GRX3-5) that is
conserved throughout evolution from bacterial to mammalian species
(21). In addition, Grx5 was found to play an important role in
protection against oxidative damage (21). These glutaredoxin-like
proteins differ from classical glutaredoxins in that they contain a
single cysteine residue at their putative active sites. Thus, they
would be able to reduce protein-mixed disulfides in a reaction that proceeds via a monothiol mechanism (21, 22). We therefore investigated
the role of Grx5 in protein S-thiolation by determining its
effect on GAPDH enzyme activity. The wild-type and grx5
mutant strains were grown to exponential phase and treated with 2 mM H2O2 to induce protein
S-thiolation (Fig. 4). Prior
to the peroxide treatment, the basal level of GAPDH activity in the
grx5 mutant was ~10-fold higher than in the wild-type
strain. Following treatment with H2O2, GAPDH
activity was inhibited by ~60 and 89% in the wild-type and
grx5 mutant strain, respectively (Fig. 4A). This reduction in GAPDH activity may have arisen due to irreversible oxidation or S-thiolation of the enzyme active site, both of
which would inhibit GAPDH activity. To distinguish between these two possibilities, cells were transferred into fresh SD medium to follow the recovery of GAPDH activity once the
H2O2 stress was removed. In the wild-type
strain, GAPDH activity recovered within 20 min to ~90% of the basal
level, before the oxidant treatment. In contrast, GAPDH activity in the
grx5 mutant was only restored to 30% of the control
activity during a 60-min recovery period, indicating that Grx5 is
required for efficient dethiolation of S-thiolated GAPDH.
The differences in GAPDH activity did not arise due to changes in
protein levels. In agreement with the measured enzyme activity, GAPDH
protein was elevated in the grx5 mutant compared with the
wild-type strain. In addition, Western blot analysis showed that
differences in protein levels between the untreated,
H2O2-treated, and recovery extracts could not
account for the changes in GAPDH activity detected (Fig.
4B).
Protein S-Thiolation in the grx5 Mutant--
To further
investigate the role of Grx5 in protein S-thiolation, cells
in which the pools of low molecular weight thiols had been radiolabeled
were challenged with H2O2 at concentrations between 1 and 4 mM for 30 min (Fig.
5). Protein synthesis in the BY4742
strain background appears to be somewhat more resistant to
cycloheximide than the CY4 strain. This was seen as the incorporation of label that could not be reversed by DTT and was therefore due to
protein synthesis rather than protein S-thiolation. A peak of GAPDH S-thiolation was seen in the wild-type strain at a
concentration of 1 mM H2O2. In
contrast, significantly higher levels of protein S-thiolation were detected in the grx5 mutant at
all concentrations of H2O2 tested. In
particular, S-thiolation of GAPDH was very prominent, and
there was elevated S-thiolation of several unknown proteins
with approximate sizes of 30, 45, 60, 70, and 100 kDa.
Loss of GRX5 Results in Delayed Dethiolation of Tdh3--
To
examine the role of Grx3-5 in dethiolation, wild-type and glutaredoxin
mutant cells were radiolabeled and treated with 2 mM
H2O2 for 30 min to induce
S-thiolation. Cells were washed to remove the
H2O2 and any unincorporated radiolabel and
resuspended in fresh minimal SD medium to follow the
dethiolation process (Fig. 6). In the
wild-type strain, dethiolation of GAPDH was ~80% complete within 5 min. In contrast, dethiolation of GAPDH was significantly slower in the
grx5 mutant compared with the wild-type strain and was only
50% complete after a 10-min recovery period (p < 0.001). However, dethiolation did occur in the grx5 mutant and was complete within 20 min. These results indicate that Grx5 is
required for the efficient dethiolation of GAPDH, but other factors can
also catalyze the reaction. These other factors do not appear to be
Grx3 or Grx4, since dethiolation of GAPDH occurred with similar
kinetics to the wild-type strain in a grx3 and a grx4 mutant (data not shown). To further examine the roles
of Grx3 and Grx4, dethiolation was examined in grx3 grx5 and
grx4 grx5 double mutant cells (Fig. 6B). Loss of
GRX3 or GRX4 in the grx5 mutant had
little or no effect on dethiolation, which was still complete within
the 20-min recovery period.
Loss of GRX5 Lowers the Glutathione Redox Ratio--
To determine
whether glutaredoxins 3-5 are required to maintain the cellular redox
state, the levels and redox ratio of glutathione were measured in
grx3-5 mutants (Table II).
Previous work has shown that glutathione is unaffected in
grx1 or grx2 mutants (20). Similarly, strains
lacking GRX3 or GRX4 contained levels of GSH and
GSSG that were comparable with the wild type, resulting in a redox
ratio of ~140 (Table II). In contrast, the grx5 mutant contained approximately 4-fold higher levels of GSSG, which resulted in
a lowered GSH/GSSG redox ratio of 46. The treatment with 2 mM H2O2 for 30 min, which was used
to induce protein S-thiolation in previous experiments
(Figs. 4-6), did not affect the wild-type strain but caused a small
increase in GSSG (27%) and decrease in the GSH redox ratio (17%).
It has long been recognized that low molecular weight thiols, such
as GSH, can interact in a reversible manner with the cysteine -SH
groups in many cellular proteins (6, 23). In particular, protein
S-thiolation/dethiolation is a dynamic process that occurs in cells under physiological conditions as well as following exposure to an oxidative stress (5, 24, 25). Models have been proposed in which
the modification of proteins by S-thiolation does not require an enzymatic activity but proceeds via the reaction of partially oxidized protein sulfydryls (thiyl radical or sulfenic acid
intermediates) with thiols such as cysteine or GSH or by thiol/disulfide exchange reactions with the oxidized disulfide form of
glutathione (GSSG) (5). However, the tight control of GAPDH
S-thiolation described in this present study indicates that
cellular factors must regulate the modification of Tdh3. The Tdh2 and
Tdh3 GAPDH isoenzymes share extensive sequence homology (98%
similarity, 96% identity), particularly in the regions surrounding their active site cysteine residues (14, 19), but the Tdh3, and not the
Tdh2 isoenzyme, is reversibly S-thiolated following exposure
to H2O2. In contrast, both GAPDH isoenzymes
could be S-thiolated in vitro using cell-free
extracts. Thus, there do not appear to be any intrinsic structural
differences to account for the difference in protein-mixed disulfide
formation between the two GAPDH isoenzymes. Our studies also show that
S-thiolation of GAPDH is a specific response to particular
oxidants, since it is not increased in response to oxidative stress
induced by treatment with diamide. This was despite the fact that
diamide readily shifts the cellular redox balance to a more oxidized
state and induces the S-thiolation of other unknown
proteins. Therefore, S-thiolation in yeast is a controlled
process that is regulated by specific cellular factors. The factors
that are responsible for the differential S-thiolation of
Tdh2 and Tdh3 remain to be identified.
To protect protein -SH groups against irreversible oxidation or to
serve an enzyme-regulatory function, protein S-thiolation must be readily reversible. Many studies have demonstrated that S-thiolated proteins formed during oxidative stress are
readily dethiolated once the stress is removed (25-27). In addition,
the reduction of mixed disulfides is stimulated by both NADH- and NADPH-dependent systems (27, 28), but the physiological
electron donors have not been identified. Most studies investigating
the factors controlling dethiolation have been performed in
vitro using radiolabeled protein-mixed disulfides as substrates.
These studies have implicated various oxidoreductases including those of the GSH/glutaredoxin and thioredoxin systems (12, 29). Glutaredoxin
appears to be the most efficient dethiolase enzyme in these in
vitro experiments. In addition, a correlation has been
demonstrated between protein-SSG reduction and glutaredoxin activity in
mammalian cells (13), and the reversible S-glutathiolation of human immunodeficiency virus type 1 protease can be catalyzed by a glutaredoxin in vitro (7). We therefore investigated
the role of yeast glutaredoxins in protein S-thiolation.
Yeast contains two classical glutaredoxin genes, designated
GRX1 and GRX2, whose protein products share
40-52% identity and 61-76% similarity with those from bacterial and
mammalian species (20). Additionally, a family of glutaredoxin-related
proteins has been identified in yeast (encoded by GRX3-5),
which is conserved throughout evolution (21). These glutaredoxin-like
proteins differ from Grx1 and Grx2 in that they contain a single
cysteine residue at their putative active sites. Thus, they would be
unable to substitute for glutaredoxins or thioredoxins as disulfide
reductases with substrates like ribonucleotide reductase that require a
dithiol mechanism (22). However, they could reduce protein-mixed
disulfides in a reaction that proceeds via a monothiol mechanism (21,
22). In agreement with this, our studies show that Grx5 is required for
dethiolation in vivo and can reduce mixed disulfides formed by GAPDH and other S-thiolated proteins. In contrast, the
dithiol glutaredoxins (Grx1, Grx2) are not affected in the formation of mixed disulfides (20) as well as in the
S-thiolation/dethiolation of GAPDH (data not shown).
Similarly, strains lacking GRX3 or GRX4 are
unaffected in the protein S-thiolation/dethiolation process.
This study shows that the grx5 mutant contains higher levels
of S-thiolated Tdh3 compared with the wild-type strain
following exposure to 1 mM H2O2.
Western blot analysis shows that the grx5 mutant contains
higher levels of GAPDH protein, so it is possible that the amount of
thiolation per molecule of GAPDH may be the same between the
grx5 mutant and the wild-type strain. However, it seems
unlikely that elevated levels of GAPDH protein can account for the
increased GAPDH thiolation observed in the grx5 mutant in
response to higher levels of H2O2 (2 and 4 mM). The level of Tdh3 S-thiolation peaks at 1 mM H2O2 in the wild-type strain, whereas thiolation is elevated at concentrations of 2 and 4 mM in the grx5 mutant. In addition, the levels
of thiolation for several unknown proteins are elevated in the
grx5 mutant compared with the wild-type strain, consistent
with a role for Grx5 in dethiolation.
Loss of GRX5 results in a delayed recovery of GAPDH enzyme
activity following oxidant treatment, with only a 2-fold recovery detected in the grx5 mutant following a 1-h growth period.
In contrast, although the grx5 mutant shows a slower rate of
Tdh3 dethiolation, it is still complete within a 20-min recovery
period. This difference presumably reflects the presence of three GAPDH isoenzymes in yeast, of which only Tdh3 can be protected against irreversible oxidation by protein S-thiolation. Thus,
dethiolation of the Tdh3 isoenzyme in the grx5 mutant would
account for the limited recovery of GAPDH activity observed. Oxidation
of the Tdh1 and Tdh2 isoenzymes will result in irreversible oxidation. Given that the grx5 mutant is extremely sensitive to
oxidative stress (21), these nonthiolated isoenzymes are likely to be readily inactivated. Thus, simply dethiolating Tdh3 in the
grx5 mutant does not restore GAPDH activity to the basal
levels found prior to the oxidative stress within a 1-h time period. It
is also interesting to note that GAPDH protein levels are elevated in
the grx5 mutant, and this may arise in a mechanism where
GAPDH synthesis is increased to compensate for any oxidized, and hence inactivated, GAPDH that may be formed.
Loss of GRX5 results in extremely slow growth and elevated
levels of protein oxidative damage compared with strains lacking GRX1-GRX4 (21). Here, we have shown that the cellular redox balance is also shifted toward a more oxidized form (measured as
GSH/GSSG) in a grx5 mutant, whereas it is unaffected by the loss of GRX1-GRX4. Thus, GRX5 appears to be the
most important glutaredoxin for protection against oxidative stress.
However, the synthetic lethality described for a grx2 grx5
and grx3 grx4 grx5 mutant indicates that there must be some
overlapping functions shared by the different glutaredoxins (21).
Although this study has indicated a role for Grx5 in the dethiolation
of protein-mixed disulfides, other activities must be required, since
the reduction of S-thiolated GAPDH can still proceed. In
addition, there may also be enzymes that regulate the forward
S-thiolation reaction. Mammalian glutaredoxins have been
shown to catalyze both the formation and reduction of mixed disulfides
(30). However, yeast glutaredoxins do not appear to be required for
S-thiolation, since mixed disulfides are formed in
grx1-grx5 mutants in response to oxidative stress. Other
enzymes that regulate protein S-thiolation may represent already known factors involved in the maintenance of cellular redox
homeostasis or as yet unidentified activities. Yeast will provide an
ideal model system to search for these factors, given the genetic and
biochemical tractability of the organism as well as the ready
availability of null mutants.
We thank Mark Ashe (University of Manchester
Institute of Science and Technology) for critical reading of the manuscript.
*
This work was supported by Biotechnology and Biological
Sciences Research Council Grant 36/C13319.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Biomolecular
Sciences, UMIST, PO Box 88, Manchester M60 1QD, UK. Tel.: 161-200-4192;
Fax: 161-236-0409; E-mail: chris.grant@umist.ac.uk.
Published, JBC Papers in Press, March 6, 2002, DOI 10.1074/jbc.M200559200
The abbreviations used are:
GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
NEM, N-ethylmaleimide;
DTT, dithiothreitol.
Regulation of Protein S-Thiolation by Glutaredoxin 5 in the Yeast Saccharomyces cerevisiae*
,
, and
School of Biochemistry and
Molecular Genetics, University of New South Wales,
Sydney, New South Wales 2052, Australia
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Yeast strains used in this study
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (51K):
[in a new window]
Fig. 1.
Protein S-thiolation in
response to oxidant treatments. A, following
35S radiolabeling of the intracellular pool of low
molecular weight sulfydryls, cells were treated with 2 mM
H2O2, tert-butylhydroperoxide
(t-BH), or diamide. Cell extracts were prepared in the
presence of NEM to prevent S-thiolation during the
extraction procedure or in the presence of DTT to reduce any
S-thiolated proteins. The levels of protein
S-thiolation are quantified as the difference in counts
incorporated between the NEM- and DTT-prepared extracts and are
expressed as cpm incorporated/µg of protein. B, following
the radiolabeling and oxidant treatments described above, proteins were
separated on a 10% SDS-PAGE gel and detected by phosphor imager
analysis. Radioactivity incorporation was confirmed to occur as a
result of S-thiolation, since it was reversed by treatment
with DTT. GAPDH is indicated with an arrow. Molecular mass
markers are indicated in kDa.

View larger version (17K):
[in a new window]
Fig. 2.
Effect of oxidant treatments on glutathione
metabolism and cell viability. Following the same oxidant
treatments as described for Fig. 1, the levels of reduced
(GSH) and oxidized (GSSG) glutathione
(A) as well as the glutathione redox ratios (B)
were determined. C, the wild-type strains (CY4) was grown to
exponential phase in SD medium and treated with 2 mM
H2O2, tert-butylhydroperoxide
(t-BT), or diamide for 1 h. Cells were diluted and
plated in triplicate onto YEPD medium to monitor cell viability at
20-min intervals. Percentage survival is expressed relative to the
untreated control cultures (100%).

View larger version (35K):
[in a new window]
Fig. 3.
Protein S-thiolation of
GAPDH in vivo and in vitro.
A, protein S-thiolation was analyzed following
treatment with 2 mM H2O2 for 30 min
in the wild-type (wt) strain (6B) and in strains deleted for
both TDH1 and TDH2 and for both TDH1
and TDH3, all encoding GAPDH isoenzymes.
S-Thiolation of GAPDH was only detected in strains
containing Tdh3 (wild type and tdh1 tdh2) but not in strains
that lacked Tdh3 (tdh1 tdh3), confirming that Tdh3 is the
S-thiolated isoenzyme of GAPDH. Radiolabeling was confirmed
to occur as a result of S-thiolation, since it was reversed
by treatment with DTT. B, cell-free extracts were prepared
from the nonstressed strains and treated with 1 mM
H2O2 for 30 min at 30 °C in
vitro. No S-thiolation was detected in the unstressed
extracts, but GAPDH was S-thiolated in response to treatment
with H2O2 in extracts from all three strains.
Radiolabeling was again confirmed to occur as a result of
S-thiolation, since it was reversed by treatment with
DTT

View larger version (25K):
[in a new window]
Fig. 4.
Inhibition and recovery of GAPDH enzyme
activity in a grx5 mutant. A, GAPDH
enzyme activity (µmol/min/µg) was determined in the wild-type
(wt) strain (BY4742) and grx5 mutant grown to
exponential phase in SD medium (control). Cells were treated
with 2 mM H2O2 for 30 min to induce
S-thiolation, and aliquots were taken to determine GAPDH
activity (+H2O2). Cells were washed and
resuspended in fresh SD medium to follow the recovery of GAPDH
activity after 20 or 60 min, respectively. Results are expressed as
percentages relative to the untreated control cultures (basal levels:
wild-type strain = 4.4 µmol/min/µg and grx5
mutant = 54.0 µmol/min/µg). B, Western blot
analysis of extracts from the wild type and grx5 mutant
probed with anti-GAPDH antibody.

View larger version (41K):
[in a new window]
Fig. 5.
Protein S-thiolation is
elevated in a grx5 mutant. Following
radiolabeling of the intracellular pool of low molecular weight
sulfydryls, wild-type (wt) (A) and
grx5 mutant cells (B) were treated with various
concentrations of H2O2 for 30 min. Proteins
were separated on 10% SDS-PAGE gels and analyzed by phosphorimaging.
Radioactivity incorporation was confirmed to occur as a result of
S-thiolation, since it was reversed by treatment with DTT.
GAPDH is indicated with an arrow, and unknown proteins that
show higher levels of S-thiolation in the grx5
mutant are indicated with an asterisk. Molecular mass
markers are indicated in kDa.

View larger version (38K):
[in a new window]
Fig. 6.
Dethiolation of Tdh3 is slower in a
grx5 mutant. Following radiolabeling of the
intracellular pool of low molecular weight sulfydryls, wild-type
(wt), grx5, grx3 grx5, and grx4
grx5 mutant cells were treated with 2 mM
H2O2 for 30 min to induce
S-thiolation. Cells were washed, resuspended in fresh SD
medium, and incubated for 20 min to follow the dethiolation
process. A, a representative experiment showing dethiolation
in the wild-type and grx5 mutant following a 10- and 20-min
recovery period. Radioactivity incorporation was confirmed to occur as
a result of S-thiolation, since it was reversed by treatment
with DTT. GAPDH is indicated with an arrow, and molecular
mass markers are indicated in kDa. B,
Tdh3-S-thiolation was quantified in the wild-type and
glutaredoxin mutants treated with the same conditions as described
above. Values shown are percentages relative to the levels of
S-thiolation induced by the H2O2
treatment (100%). All data points represent the mean of at least three
independent determinations, with A showing a single
representative experiment.
Loss of GRX5 lowers the glutathione redox ratio
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Carmel-Harel, O.,
and Storz, G.
(2000)
Annu. Rev. Microbiol.
54,
439-461[CrossRef][Medline]
[Order article via Infotrieve] 2.
Grant, C. M.
(2001)
Mol. Microbiol.
39,
533-541[CrossRef][Medline]
[Order article via Infotrieve] 3.
Rietsch, A.,
and Beckwith, J.
(1998)
Annu. Rev. Genet.
32,
163-184[CrossRef][Medline]
[Order article via Infotrieve] 4.
Coan, C., Ji, J.-Y.,
Hideg, K.,
and Mehlhorn, R. J.
(1992)
Arch. Biochem. Biophys.
295,
369-378[CrossRef][Medline]
[Order article via Infotrieve] 5.
Thomas, J. A.,
Poland, B.,
and Honzatko, R.
(1995)
Arch. Biochem. Biophys.
319,
1-9[CrossRef][Medline]
[Order article via Infotrieve] 6.
Klatt, P.,
and Lamas, S.
(2000)
Eur. J. Biochem.
267,
4928-4944[Medline]
[Order article via Infotrieve] 7.
Davis, D. A.,
Newcomb, F. M.,
Starke, D. W.,
Ott, D. E.,
Mieyal, J. J.,
and Yarchoan, R.
(1997)
J. Biol. Chem.
272,
25935-25940 8.
Obin, M.,
Shang, F.,
Gong, X.,
Handelman, G.,
Blumberg, J.,
and Taylor, A.
(1998)
FASEB J.
12,
561-569 9.
Klatt, P.,
Molina, E. P., De,
Lacoba, M. G.,
Padilla, C. A.,
Martinez-Galisteo, E.,
Barcena, J. A.,
and Lamas, S.
(1999)
FASEB J.
13,
1481-1490 10.
Grant, C. M.,
Perrone, G.,
and Dawes, I. W.
(1998)
Biochem. Biophys. Res. Commun.
253,
893-898[CrossRef][Medline]
[Order article via Infotrieve] 11.
Grant, C. M.,
Quinn, K. A.,
and Dawes, I. W.
(1999)
Mol. Cell. Biol.
19,
2650-2656 12.
Jung, C.-H.,
and Thomas, J. A.
(1996)
Arch. Biochem. Biophys.
335,
61-72[CrossRef][Medline]
[Order article via Infotrieve] 13.
Chrestensen, C. A.,
Starke, D. W.,
and Mieyal, J. J.
(2000)
J. Biol. Chem.
275,
26556-26565 14.
Mcalister, L.,
and Holland, M. J.
(1985)
J. Biol. Chem.
260,
15019-15027 15.
Meister, A.
(1988)
J. Biol. Chem.
263,
17205-17208 16.
Grant, C. M.,
MacIver, F. M.,
and Dawes, I. W.
(1996)
Mol. Microbiol.
22,
739-746[CrossRef][Medline]
[Order article via Infotrieve] 17.
Muller, E. G. D.
(1996)
Mol. Biol. Cell
7,
1805-1813[Abstract] 18.
Kosower, N. S.,
and Kosower, E. M.
(1995)
Methods Enzymol.
251,
123-133[Medline]
[Order article via Infotrieve] 19.
McAlister, L.,
and Holland, M. J.
(1985)
J. Biol. Chem.
260,
15013-15018 20.
Luikenhuis, S.,
Dawes, I. W.,
and Grant, C. M.
(1997)
Mol. Biol. Cell
9,
1081-1091 21.
Rodriguez-Manzaneque, M. T.,
Ros, J.,
Cabiscol, E.,
Sorribas, A.,
and Herrero, E.
(1999)
Mol. Cell. Biol.
19,
8180-8190 22.
Bushweller, J. H.,
Aslund, F.,
Wuthrich, K.,
and Holmgren, A.
(1992)
Biochemistry
31,
9288-9293[CrossRef][Medline]
[Order article via Infotrieve] 23.
Cotgreave, I. A.,
and Gerdes, R. G.
(1998)
Biochem. Biophys. Res. Commun.
242,
1-9[CrossRef][Medline]
[Order article via Infotrieve] 24.
Thomas, J. A.,
Chai, Y.-C.,
and Jung, C.-H.
(1994)
Methods Enzymol.
233,
385-395[Medline]
[Order article via Infotrieve] 25.
Seres, T.,
Ravichandran, V.,
Moriguchi, T.,
Rokutan, K.,
Thomas, J. A.,
and Johnston, R. B.
(1996)
J. Immunol.
156,
1973-1980[Abstract] 26.
Schuppe, I.,
Moldeus, P.,
and Cotgreave, I. A.
(1992)
Biochem. Pharmacol.
44,
1757-1764[CrossRef][Medline]
[Order article via Infotrieve] 27.
Schuppe-Koistinen, I.,
Gerdes, R.,
Moldeus, P.,
and Cotgreave, I. A.
(1994)
Arch. Biochem. Biophys.
315,
226-234[CrossRef][Medline]
[Order article via Infotrieve] 28.
Miller, R. M.,
Park, E. M.,
and Thomas, J. A.
(1991)
Arch. Biochem. Biophys.
287,
112-120[CrossRef][Medline]
[Order article via Infotrieve] 29.
Yoshitake, S.,
Nanri, H.,
Fernando, M. R.,
and Minakimi, S.
(1994)
J. Biochem. (Tokyo)
116,
42-46 30.
Ruoppolo, M.,
Lundstrom-Ljung, J.,
Talamo, F.,
Pucci, P.,
and Marino, G.
(1997)
Biochemistry
36,
12259-12267[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
L. Michelet, M. Zaffagnini, H. Vanacker, P. Le Marechal, C. Marchand, M. Schroda, S. D. Lemaire, and P. Decottignies In Vivo Targets of S-Thiolation in Chlamydomonas reinhardtii J. Biol. Chem., August 1, 2008; 283(31): 21571 - 21578. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamamoto, J. Ueda, N. Yamamoto, N. Hashikawa, and H. Sakurai Role of Heat Shock Transcription Factor in Saccharomyces cerevisiae Oxidative Stress Response Eukaryot. Cell, August 1, 2007; 6(8): 1373 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Melchers, N. Dirdjaja, T. Ruppert, and R. L. Krauth-Siegel Glutathionylation of Trypanosomal Thiol Redox Proteins J. Biol. Chem., March 23, 2007; 282(12): 8678 - 8694. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Marques, D. Mojzita, M. A. Amorim, T. Almeida, S. Hohmann, P. Moradas-Ferreira, and V. Costa The Pep4p vacuolar proteinase contributes to the turnover of oxidized proteins but PEP4 overexpression is not sufficient to increase chronological lifespan in Saccharomyces cerevisiae Microbiology, December 1, 2006; 152(12): 3595 - 3605. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ojeda, G. Keller, U. Muhlenhoff, J. C. Rutherford, R. Lill, and D. R. Winge Role of Glutaredoxin-3 and Glutaredoxin-4 in the Iron Regulation of the Aft1 Transcriptional Activator in Saccharomyces cerevisiae J. Biol. Chem., June 30, 2006; 281(26): 17661 - 17669. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Molina, G. Belli, M. A. de la Torre, M. T. Rodriguez-Manzaneque, and E. Herrero Nuclear Monothiol Glutaredoxins of Saccharomyces cerevisiae Can Function as Mitochondrial Glutaredoxins J. Biol. Chem., December 10, 2004; 279(50): 51923 - 51930. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Belli, M. M. Molina, J. Garcia-Martinez, J. E. Perez-Ortin, and E. Herrero Saccharomyces cerevisiae Glutaredoxin 5-deficient Cells Subjected to Continuous Oxidizing Conditions Are Affected in the Expression of Specific Sets of Genes J. Biol. Chem., March 26, 2004; 279(13): 12386 - 12395. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Wheeler, E. W. Trotter, I. W. Dawes, and C. M. Grant Coupling of the Transcriptional Regulation of Glutathione Biosynthesis to the Availability of Glutathione and Methionine via the Met4 and Yap1 Transcription Factors J. Biol. Chem., December 12, 2003; 278(50): 49920 - 49928. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tamarit, G. Belli, E. Cabiscol, E. Herrero, and J. Ros Biochemical Characterization of Yeast Mitochondrial Grx5 Monothiol Glutaredoxin J. Biol. Chem., July 3, 2003; 278(28): 25745 - 25751. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Laliberte, D. G. Perregaux, L. R. Hoth, P. J. Rosner, C. K. Jordan, K. M. Peese, James. F. Eggler, M. A. Dombroski, K. F. Geoghegan, and C. A. Gabel Glutathione S-Transferase Omega 1-1 Is a Target of Cytokine Release Inhibitory Drugs and May Be Responsible for Their Effect on Interleukin-1beta Posttranslational Processing J. Biol. Chem., May 2, 2003; 278(19): 16567 - 16578. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pauwels, B. Vergauwen, F. Vanrobaeys, B. Devreese, and J. J. Van Beeumen Purification and Characterization of a Chimeric Enzyme from Haemophilus influenzae Rd That Exhibits Glutathione-dependent Peroxidase Activity J. Biol. Chem., May 2, 2003; 278(19): 16658 - 16666. [Abstract] [Full Text] [PDF] |
||||
| ||||||